We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




FOXM1 Oncogene Interferes with Stem Cell Differentiation and Promotes Cancer-Like Cell Behavior

By LabMedica International staff writers
Posted on 24 Nov 2010
The role of the FOXM1 oncogene in initiation of cancer-like cell transformations has been defined using a three-dimensional cell culture system.

Investigators at Queen Mary University (London, United Kingdom) worked with cultures of human keratinocytes with stem/progenitor cell properties growing in a functional three-dimensional organotypic epithelial tissue regeneration system. More...
Use of this three-dimensional tissue culture system allowed researchers to perform experiments on manipulated human cells without provoking ethical issues associated with human or animal subjects.

They reported in the November 9, 2010, online edition of the journal Cancer Research that aberrant upregulation of FOXM1 in adult human epithelial stem cells induced a precancer phenotype, a condition similar to human hyperplasia. They showed that excessive expression of FOXM1 exploited the inherent self-renewal proliferation potential of stem cells by interfering with the differentiation pathway, thereby expanding the progenitor cell compartment. It was therefore hypothesized that FOXM1 induced cancer initiation through stem/progenitor cell expansion.

Senior author Dr. Muy-Tek Teh, lecturer in head and neck cancer at Queen Mary University, said, "Now we know that FOXM1 plays a key role in cancer initiation we aim to translate our basic findings into clinically useful molecular diagnostic tests to detect cancer growth at early stages. Furthermore, understanding the origin of cancer initiation may unveil new research opportunities for finding effective antitumor drugs that stop or prevent cancer at its earliest incipient stage.”

Related Links:

Queen Mary University




New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.